Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis

ClinicalTrials.gov ID: NCT04036435

Public ClinicalTrials.gov record NCT04036435. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 2:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multi-Center Extension Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects With Moderate-to-Severe Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the long-term safety and efficacy of the drug Deucravacitinib (BMS-986165) in participants who have been previously enrolled in an applicable Phase 3 psoriasis study. In addition, the study includes a vaccine cohort to evaluate whether deucravacitinib impacts the humoral immune response to 2 non-live vaccines, the Pneumovax 23 vaccine (pneumococcus), a T-cell independent vaccine, and the Boostrix vaccine (tetanus toxoid), a T-cell dependent vaccine. Additionally, this vaccine cohort assesses the safety of administering these vaccines to subjects with psoriasis receiving deucravacitinib compared to those receiving a placebo.

Study identification

NCT ID
NCT04036435
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
1,466 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 12, 2019 (Actual)
Primary completion
Jul 21, 2026 (Actual)
Completion
Jul 21, 2026 (Actual)
Last update posted
Sep 10, 2026

2019 – 2026

United States locations

U.S. sites
101
U.S. states
29
U.S. cities
80
Facility City State ZIP Site status
Total Skin and Beauty Dermatology Center Birmingham Alabama 35205 —
Local Institution - 0278 Birmingham Alabama 35233 —
Alliance Dermatology and Mohs Center - Phoenix Phoenix Arizona 85032 —
Arizona Research Center Phoenix Arizona 85053 —
Synexus - Orange Grove Family Practice Tucson Arizona 85741 —
Johnson Dermatology Fort Smith Arkansas 72916 —
Burke Pharmaceutical Research Hot Springs Arkansas 71913 —
Northwest Arkansas Clinical Trials Center, PLLC Rogers Arkansas 72758 —
Local Institution - 0046 Fountain Valley California 92708 —
Local Institution - 0206 Fresno California 93720 —
Local Institution - 0017 Irvine California 92697 —
Interspond - Long Beach Clinical Trials Long Beach California 90806 —
Dermatology Research Associates - Los Angeles Los Angeles California 90045-3606 —
Local Institution - 0236 Los Angeles California 90057 —
University of California San Diego Health Systems San Diego California 92122 —
Therapeutics Clinical Research San Diego California 92123 —
University Dermatology Group San Diego California 92123 —
Local Institution - 0094 San Luis Obispo California 93405 —
Clinical Science Institute Santa Monica California 90404 —
NorthBay Clinical Research Santa Rosa California 95405 —
Synexus - Santa Rosa Santa Rosa California 95405 —
Local Institution - 0042 Sherman Oaks California 91403 —
Care Access Research - Walnut Creek Walnut Creek California 94598 —
New England Research Associates Bridgeport Connecticut 06606 —
Stamford Therapeutics Consortium Stamford Connecticut 06905 —
Local Institution - 0170 Boca Raton Florida 33486 —
ERN - Accel Research Sites DeLand Florida 32720 —
Indago Research and Health Center Hialeah Florida 33012 —
LCC Medical Research Miami Florida 33126 —
International Dermatology Research Miami Florida 33144 —
Well Pharma Medical Research Miami Florida 33173 —
Local Institution - 0216 Miami Florida 33176 —
Interspond - Savin Medical Group Miami Lakes Florida 33014 —
Local Institution - 0007 Miami Lakes Florida 33014 —
Local Institution - 0198 Port Orange Florida 32127 —
Local Institution - 0233 Tampa Florida 33609 —
Local Institution - 0008 Tampa Florida 33614-7118 —
Local Institution - 0013 Marietta Georgia 30060 —
Local Institution - 0235 Sandy Springs Georgia 30328 —
Treasure Valley Dermatology & Skin Cancer Center Meridian Idaho 83642 —
Springfield Clinic Springfield Illinois 62703 —
Dundee Dermatology West Dundee Illinois 60118 —
Deaconess Clinic Downtown Evansville Indiana 47708 —
Clinical Research Advantage - Evansville - South Kenmore Drive Evansville Indiana 47714 —
Dawes Fretzin Dermatology Group Indianapolis Indiana 46250 —
Local Institution - 0020 Plainfield Indiana 46168 —
The South Bend Clinic South Bend Indiana 46617 —
Local Institution - 0040 Louisville Kentucky 40217 —
Shondra L. Smith, M.D. Lake Charles Louisiana 70605-1213 —
Clinical Trials of America - Monroe Monroe Louisiana 71201 —
Tufts Medical Center Boston Massachusetts 02111 —
Local Institution - 0291 Boston Massachusetts 02215 —
Ora Chestnut Hill Massachusetts 02467 —
Local Institution - 0234 Methuen Massachusetts 01844 —
DermCare Experts Quincy Massachusetts 02169 —
David Fivenson MD Dermatology Ann Arbor Michigan 48103 —
Hamzavi Dermatology Fort Gratiot Michigan 48059 —
Local Institution - 0025 Troy Michigan 48084 —
Associated Skin Care Specialists - Minnesota Clinical Study Center New Brighton Minnesota 55112 —
Washington University School of Medicine - West County Dermatology St Louis Missouri 63141 —
Clinical Research Consortium - Las Vegas Las Vegas Nevada 89119 —
Hassman Research Institute Berlin New Jersey 08009 —
Local Institution - 0016 East Windsor New Jersey 08520 —
Forest Hills Dermatology Group Kew Gardens New York 11374 —
Local Institution - 0058 New York New York 10028 —
Local Institution - 0218 Stony Brook New York 11790 —
Montefiore Medical Center - Bronx The Bronx New York 10467 —
PMG Research of Cary Cary North Carolina 27615 —
Wilmington Dermatology Center Wilmington North Carolina 28405 —
Radiant Research - Columbus Columbus Ohio 43212 —
ClinOhio Research Services Columbus Ohio 43213 —
Local Institution - 0176 Fairborn Ohio 45324 —
Central Sooner Research Norman Oklahoma 73071 —
Unity Clinical Research Oklahoma City Oklahoma 73118 —
Local Institution - 0167 Portland Oregon 97201 —
Local Institution - 0009 Portland Oregon 97210 —
Local Institution - 0045 Exton Pennsylvania 19341 —
Local Institution - 0282 Pittsburgh Pennsylvania 15213 —
Radiant Research - Anderson Anderson South Carolina 29621 —
Clinical Research Center of the Carolinas Charleston South Carolina 29407 —
Local Institution - 0037 Greer South Carolina 29651 —
Coastal Carolina Research Center - Mount Pleasant North Charleston South Carolina 29405 —
Local Institution - 0004 Rapid City South Dakota 57702 —
Rivergate Dermatology - Main Office Goodlettsville Tennessee 37072 —
Clinical Research Solutions - Jackson Jackson Tennessee 38305 —
Dermatology Associates of Knoxville Knoxville Tennessee 37917 —
The Skin Wellness Center Knoxville Tennessee 37922 —
Local Institution - 0006 Arlington Texas 76011 —
Bellaire Dermatology Bellaire Texas 77401 —
Local Institution - 0015 Dallas Texas 75230 —
Local Institution - 0195 Dallas Texas 75231 —
Local Institution - 0030 Dallas Texas 75234 —
Menter Dermatology Research Institute Dallas Texas 75246 —
Center for Clinical Studies - Texas Medical Center Houston Texas 77004 —
Austin Institute for Clinical Research - Pflugerville Pflugerville Texas 78660 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78218 —
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229 —
Interspond - Acclaim Dermatology Sugar Land Texas 77479 —
Interspond - Houston Center for Clinical Research Sugar Land Texas 77479 —
Center for Clinical Studies - Webster Webster Texas 77598 —
Local Institution - 0265 Seattle Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 201 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04036435, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 10, 2026 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04036435 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →